NUCLEOLIN and cancer: Interestingly, nucleolin is overexpressed and partially localized on the cell surface of cancer cells (115), becoming it a preferential target for the delivery of anticancer agents that target surface nucleolin for potential effective and nontoxic cancer therapy.